
Here are highlights from the second day of this year’s APA Annual Meeting.
Here are highlights from the second day of this year’s APA Annual Meeting.
Here are highlights from the first day of this year’s APA Annual Meeting.
What are the connections between cannabis use and the onset of psychotic disorders?
What is the potential impact of social media overuse and mental health crises in young patients?
An expert gives us a preview of the clinical pearls clinicians can expect from his presentations at this year’s APA Annual Meeting.
How can psychiatric clinicians improve outcomes for this unique patient population?
The experts weighed in on a wide variety of psychiatric issues for the April issue of Psychiatric Times.
In this CME article, discuss and describe the epidemiology, assessment, and evidence-based treatment of insomnia in older adults.
What is the efficacy of ECT for the treatment of dementia?
Here are highlights from the week in Psychiatric Times.
What does the recent FDA clearance of this treatment for adolescents mean for the future of MDD treatment?
What are the most effective approaches to SUD treatment in this unique patient population?
Learn more about a feasible, scalable, effective model of care that is a step away from the forced dichotomy of inpatient and outpatient care.
Are you ready to discuss the Black youth crisis and the need for dynamic conversations?
How can consultation-liaison psychiatry help identify BPD and facilitate effective communication between patients and medical teams during these patients’ admissions?
How can telehealth aid in the treatment of opioid use disorders in this patient population?
Here’s why you should attend the Yale Child Study Center Black Youth Mental Health Case Conference.
How can consulting psychiatrists help the team provide culturally appropriate care for diverse patient populations?
From a promising new intervention for treatment-resistant depression to another look at the STAR*D controversy, here are highlights from the week in Psychiatric Times.
This treatment is now the first and only TMS treatment that is FDA-cleared for this patient population.
The world would benefit from the values and knowledge of Indigenous individuals, who have been displaced and colonized.
What is new in research on COVID-19?
What is new in research on child and adolescent psychiatry?
What is new in research on cannabis?
From personality disorders and common comorbidities to the effects of abortion bans on mental health, here are highlights from the week in Psychiatric Times.